CONDENSED CONSOLIDATED STATEMENTS OF LOSS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended	9 Months Ended
Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Statement [Abstract]
Net product revenue	$ 50,025	$ 7,014	$ 118,707	$ 8,510
Cost of products sold	6,155	117	10,465	153
Gross profit	43,870	6,897	108,242	8,357
Operating expenses:
Research and development expenses	3,803	2,849	10,922	10,902
Selling, general and administrative expenses	40,394	39,158	136,422	110,404
Total operating expense	44,197	42,007	147,344	121,306
Operating loss	(327)	(35,110)	(39,102)	(112,949)
Investment and other income, net	610	903	3,114	1,719
Interest expense	(2,820)	(1,978)	(8,128)	(7,532)
Loss on extinguishment of debt	0	0	0	(13,129)
Loss before income taxes	(2,537)	(36,185)	(44,116)	(131,891)
Income tax provision (benefit)	88	89	(327)	(401)
Net loss	$ (2,625)	$ (36,274)	$ (43,789)	$ (131,490)
Net loss per share - basic (in dollars per share)	$ (0.03)	$ (0.41)	$ (0.46)	$ (1.71)
Net loss per share - diluted (in dollars per share)	$ (0.03)	$ (0.41)	$ (0.46)	$ (1.71)
Weighted average number of shares outstanding - basic (in shares)	96,300	89,380	94,720	76,931
Weighted average number of shares outstanding - diluted (in shares)	96,300	89,380	94,720	76,931

The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.

Name:	us-gaap_CostOfGoodsAndServicesSold
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.